1. Home
  2. ACET vs SEAT Comparison

ACET vs SEAT Comparison

Compare ACET & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.58

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

HOLD

Current Price

$6.55

Market Cap

69.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
SEAT
Founded
1947
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
69.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
SEAT
Price
$8.58
$6.55
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$65.33
$32.94
AVG Volume (30 Days)
208.6K
108.7K
Earning Date
03-05-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$643,775,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.15
$6.06
52 Week High
$17.44
$95.40

Technical Indicators

Market Signals
Indicator
ACET
SEAT
Relative Strength Index (RSI) 78.42 43.69
Support Level $7.76 $6.25
Resistance Level $8.55 $7.10
Average True Range (ATR) 0.45 0.49
MACD -0.14 0.01
Stochastic Oscillator 73.85 28.74

Price Performance

Historical Comparison
ACET
SEAT

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: